Axell-House, D.B.; Wurster, S.; Jiang, Y.; Kyvernitakis, A.; Lewis, R.E.; Tarrand, J.J.; Raad, I.I.; Kontoyiannis, D.P.
Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. J. Fungi 2021, 7, 217.
https://doi.org/10.3390/jof7030217
AMA Style
Axell-House DB, Wurster S, Jiang Y, Kyvernitakis A, Lewis RE, Tarrand JJ, Raad II, Kontoyiannis DP.
Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. Journal of Fungi. 2021; 7(3):217.
https://doi.org/10.3390/jof7030217
Chicago/Turabian Style
Axell-House, Dierdre B., Sebastian Wurster, Ying Jiang, Andreas Kyvernitakis, Russell E. Lewis, Jeffrey J. Tarrand, Issam I. Raad, and Dimitrios P. Kontoyiannis.
2021. "Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer" Journal of Fungi 7, no. 3: 217.
https://doi.org/10.3390/jof7030217
APA Style
Axell-House, D. B., Wurster, S., Jiang, Y., Kyvernitakis, A., Lewis, R. E., Tarrand, J. J., Raad, I. I., & Kontoyiannis, D. P.
(2021). Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer. Journal of Fungi, 7(3), 217.
https://doi.org/10.3390/jof7030217